lomustine has been researched along with Angiogenesis, Pathologic in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glioblastomas are rich in blood vessels (i." | 2.58 | Anti-angiogenic therapy for high-grade glioma. ( Ameratunga, M; Grant, R; Khasraw, M; Pavlakis, N; Simes, J; Wheeler, H, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kickingereder, P | 1 |
| Brugnara, G | 1 |
| Hansen, MB | 1 |
| Nowosielski, M | 1 |
| Pflüger, I | 1 |
| Schell, M | 1 |
| Isensee, F | 1 |
| Foltyn, M | 1 |
| Neuberger, U | 1 |
| Kessler, T | 1 |
| Sahm, F | 1 |
| Wick, A | 1 |
| Heiland, S | 1 |
| Weller, M | 1 |
| Platten, M | 1 |
| von Deimling, A | 1 |
| Maier-Hein, KH | 1 |
| Østergaard, L | 1 |
| van den Bent, MJ | 1 |
| Gorlia, T | 1 |
| Wick, W | 1 |
| Bendszus, M | 1 |
| Ameratunga, M | 1 |
| Pavlakis, N | 2 |
| Wheeler, H | 2 |
| Grant, R | 2 |
| Simes, J | 1 |
| Khasraw, M | 2 |
| Ameratunga, MS | 1 |
2 reviews available for lomustine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Anti-angiogenic therapy for high-grade glioma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brai | 2018 |
Antiangiogenic therapy for high-grade glioma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brai | 2014 |
1 trial available for lomustine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Bevacizumab; Brain Neoplasms; Contrast M | 2020 |